LearnSkin
Supported by independent educational grants from Janssen Biotech, Inc and UCB

While topical steroids are widely used for mild to moderate psoriasis, several new nonsteroidal medications have emerged with recent FDA approvals. Topical approaches for treating itch and inflammation will be discussed.

Learning Objectives: 

  • Participants will review the basic science behind topical therapies in psoriasis including the role of the aryl hydrocarbon receptor and the phosphodiesterase 4 pathway.  
  • Participants will describe the clinical evidence for emerging topical therapies such as tapinarof and roflumilast. 
  • Participants will incorporate the use of topical medications into the management of many variants of psoriasis.

Faculty

User: Neal Bhatia
Neal Bhatia
MD

Dr. Neal Bhatia is a board-certified dermatologist in San Diego, California. He serves as Director of Clinical Dermatology at Therapeutics Clinical Research. He is as chief medical editor for Practical Dermatology.He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology. Aside from teaching at medical conferences, he sits on several editorial boards and is an active teacher for dermatologists, industry, and patients.

View Bio

Editors

User: jasonhawkes@learnskin.com
Jason Ezra Hawkes

Dr. Hawkes is a board-certified dermatologist in the greater Sacramento area. He completed his medical school and residency at the University of Utah. During medical school, he completed a fellowship in translational immunology in the NIH-HHMI Research Scholars Program. He also received a Master’s Degree in Clinical Investigation from Rockefeller University, where he was Chief Clinical Scholar and Principal and sub-Investigator on multiple human research protocols in the Laboratory for Investigative Dermatology. He has held academic appointments in the Departments of Dermatology at the University of Utah, University of California-Davis, Icahn School of Medicine at Mount Sinai.

Dr. Hawkes is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee. He also serves as the official delegate of the AAD as a member of the international guidelines and workgroup committee for urticaria. His research has been funded by the NIH, NSF, NPF, and Dermatology Foundation, and he is the recipient of several teaching awards including NPF Outstanding Educator in Psoriatic Disease and Exceptional Teacher of the Year in the Department of Dermatology at Mount Sinai. His primary clinical and research interests include novel immune therapies for inflammatory conditions like psoriasis, atopic dermatitis, HS, alopecia areata, vitiligo, and urticaria.

View Bio

Related Courses

LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2024.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!